• 26 Innovation Walk

    3800 Clayton

1994 …2021
If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

After completing his PhD at the University of New South Wales in 1999, Dr Harrison joined Prince Henry’s Institute in Melbourne. His postdoctoral training was at the Salk Institute for Biological Sciences (La Jolla, California) in the laboratory of Professor Wylie Vale as a NHMRC CJ Martin Training Fellow. On returning to Australia, he established the Growth Factor Signalling Laboratory at Prince Henry’s Institute (later the Hudson Institute). In 2016, Dr Harrison moved his lab to the Department of Physiology, Monash University.

Dr Harrison’s research focuses on the mechanisms underlying the synthesis and activation of TGF-β proteins, and the roles these growth factors play in skeletal muscle and the female reproductive system.

Dr Harrison has been a member of the ESA Council since 2014 and treasurer since 2017.

Supervision interests

Keywords

  • Inhibin and activin
  • muscle wasting
  • folliculogenesis
  • TGFbeta proteins

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2011 2021

Research Output 1994 2018

Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy

Marini, K., Croucher, D. R., McCloy, R. A., Vaghjiani, V., Gonzalez-Rajal, A., Hastings, J. F., Chin, V. T., Szczepny, A., Kostyrko, K., Marquez, C., Jayasekara, W. S. N., Alamgeer, M., Boolell, V., Han, J. Z. R., Waugh, T., Lee, H. C., Oakes, S. R., Kumar, B., Harrison, C. A., Hedger, M. P. & 13 othersLorensuhewa, N., Kita, B., arrow, R. B., Robinson, B. W. S., de Kretser, D. M., Wu, J., Ganju, V., Sweet-Cordero, E. A., Burgess, A., Martelotto, L. G., Rossello, F. J., Cain, J. & Watkins, D. N., 25 Jul 2018, In : Science Translational Medicine. 10, 451, 13 p., eaat3504.

Research output: Contribution to journalArticleResearchpeer-review

Molecular characterization of latent GDF8 reveals mechanisms of activation

Walker, R. G., McCoy, J. C., Czepnik, M., Mills, M. J., Hagg, A., Walton, K. L., Cotton, T. R., Hyvönen, M., Lee, R. T., Gregorevic, P., Harrison, C. A. & Thompson, T. B., 30 Jan 2018, In : Proceedings of the National Academy of Sciences of the United States of America. 115, 5, p. E866-E875 10 p.

Research output: Contribution to journalArticleResearchpeer-review

BMP15 mutations associated with primary ovarian insufficiency reduce expression, activity, or synergy with gdf9

Patino, L. C., Walton, K. L., Mueller, T. D., Johnson, K. E., Stocker, W., Richani, D., Agapiou, D., Gilchrist, R. B., Laissue, P. & Harrison, C. A., 1 Mar 2017, In : Journal of Clinical Endocrinology and Metabolism. 102, 3, p. 1009-1019 11 p.

Research output: Contribution to journalArticleResearchpeer-review

Multiple soluble TGF-β receptors in addition to soluble endoglin are elevated in preeclamptic serum and they synergistically inhibit TGF-β signaling

Wang, Y., Chen, Q., Zhao, M., Walton, K., Harrison, C. & Nie, G., 1 Aug 2017, In : Journal of Clinical Endocrinology and Metablism. 102, 8, p. 3065-3074 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Specific targeting of TGF-β family ligands demonstrates distinct roles in the regulation of muscle mass in health and disease

Chen, J., Walton, K. L., Hagg, A. G., Colgan, T. D., Johnson, K. E., Qian, H., Gregorevic, P. & Harrison, C. A., 27 Jun 2017, In : Proceedings of the National Academy of Sciences. 114, 26, p. E5266-E5275 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Activities 2014 2014

  • 1 Committees and working groups

Council Member and Treasurer

Craig Harrison (Fellow)
2014 → …

Activity: External Academic EngagementCommittees and working groups